AVANGARD, OOO, Moscow

Accounting reports

Previously

Name	AVANGARD, OOO
INN	7727321779
KPP	773001001
OGRN	1177746585114
OKPO	15992935
Address	121087, G.MOSKVA, ul. Novozavodskaya, d. 8, pomesch. 8/1
Phone	+7 (910) 002-59-74

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities AVANGARD, OOO according to EGRUL
46.22	Core activity	Wholesale of other intermediate products of wood and wooden building components
46.31	Additional activity	Wholesale trade in fruit and vegetables
46.33	Additional activity	Wholesale trade of dairy products, eggs and edible oils and fats

Registration information

Registration date	14.06.2017

Description

AVANGARD, OOO (Moscow; INN 7727321779) was registered on 14 Jun 2017. The company's authorized capital as of July 1, 2012 was 50000 rub.

Principal activities of AVANGARD, OOO: wholesale of other intermediate products of wood and wooden building components (46.22), wholesale trade in fruit and vegetables (46.31), wholesale trade of dairy products, eggs and edible oils and fats (46.33).

Industry

46 - Wholesale trade (excluding motor vehicles)
- 46.3 - Wholesale trade of food, beverages and tobacco
  - 46.31 - Wholesale trade in fruit and vegetables
  - 46.33 - Wholesale trade of dairy products, eggs and edible oils and fats
- 46.2 - Wholesale of grain, unmanufactured tobacco, seeds and animal feeds
  - 46.22 - Wholesale of other intermediate products of wood and wooden building components

Economic indicators

2023

Net loss (RAS) of REABMEDIKA, OOO dropped over 2023 13.90 times to 1.31 million RUB from 18.26 million RUB KAgent.Entities.Balance, the company informed.

2022

Net loss (RAS) of REABMEDIKA, OOO increased by 9.86% to 18.26 million RUB from 16.62 million RUB over 2021, the company informed.

Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 31.44 million RUB in 2021.

2021

Net loss (RAS) of REABMEDIKA, OOO increased by 4.20% to 16.62 million RUB from 15.95 million RUB over 2020, the company informed.

Revenue decreased in the accounting period 3.05 times to 31.44 million RUB from 95.85 million RUB in 2020.

2020

Net loss (RAS) of REABMEDIKA, OOO increased by 35.84% to 15.95 million RUB from 11.74 million RUB over 2019, the company informed.

Revenue increased in the accounting period 13.10 times to 95.85 million RUB from 7.32 million RUB over 2019.

2019

Net loss (RAS) of REABMEDIKA, OOO increased by 35.48% to 11.74 million RUB from 8.67 million RUB over 2018, the company informed.

Revenue increased in the accounting period 5.28 times to 7.32 million RUB from 1.39 million RUB over 2018; cost of goods sold grew 1,288.60 times to 6.44 million RUB from 5.00 thousand RUB; sales loss grew by 31.49% to 11.89 million RUB from 9.05 million RUB.

2018

Net loss (RAS) of REABMEDIKA, OOO increased 3.11 times to 8.67 million RUB from 2.79 million RUB over 2017, the company informed.

Sales loss grew 3.04 times to 9.05 million RUB from 2.98 million RUB.

2017

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 300 159

Reports

17 430 675

Rrocessed requests

Extract from EGRUL:

Today, 4:26 PM

Accounting reports:

Today, 4:22 PM